Home - Gilde Healthcare

Enabling
better care
at lower cost

One firm with two strategies
Gilde Healthcare is a specialized healthcare investor with over €2.6bn under management across two fund strategies: Venture&Growth and Private Equity. Gilde Healthcare is headquartered in Utrecht, the Netherlands with local offices in Frankfurt, Germany and Boston, US.

Utrecht, The Netherlands
Frankfurt am Main, Germany
Boston, United States of America

Venture&Growth

About Venture&Growth

Private Equity

About Private Equity

Investment philosophy

Gilde Healthcare invests in businesses enabling better care at lower cost.
40
years in business

Venture&Growth

Gilde Healthcare Venture&Growth invests in healthtech and therapeutics. The Venture&Growth fund supports fast growing companies in Europe and North America.
69
Venture&Growth companies in portfolio
under management
2.6B

Private Equity

Gilde Healthcare Private Equity participates in profitable European lower mid-market healthcare companies. The Private Equity fund targets healthcare providers, suppliers of medical products and service providers to the healthcare sector.
24
Private Equity companies in portfolio
40
years in business
69
Venture&Growth companies in portfolio
under management
2.6B
24
Private Equity companies in portfolio

Team

Our transatlantic team, comprising sector specialists with operating and financial backgrounds leverages its deep industry knowledge to achieve outsized returns on companies that deliver better care at lower costs.

Portfolio

Gilde Healthcare invests in firms that support the healthcare sector such as healthcare providers, medical product suppliers, and service providers, as well as disruptive companies active in medtech, digital health, medical instruments, and therapeutics.

Responsible Investment at Gilde Healthcare:

We focus on both ESG and Impact: ESG sets the foundation with responsible practices, while Impact drives measurable change in healthcare. Check out our impact cases to see how we’re making a difference.

Read more about ESG/impact

News

Keep up to date with Gilde Healthcare announcements and portfolio company news.

Gilde Healthcare company CatalYm announces leadership changes to accelerate visugromab late-stage clinical development

Gilde Healthcare company CatalYm, a world-leader in neutralizing GDF-15 in cancer and cachexia, today announced changes to its executive leadership team to support its next stage of growth. The appointments...

15 September 2025